To support its development, Uncommon, a startup leveraging cell technologies for the health of humanity, starting with cultivated pork, has raised €28 million in Series A funding, bringing the total raised to €32.5 million. The funding will be used to continue to bring the cost of goods down, apply for regulatory approval,  and scale up production at its pilot manufacturing facility at Cambridge Technopark, whilst doubling the team over the next 18 months to further expand the company’s capabilities.

Source: Cambridge-based Uncommon raises €28 million to scale cultivated pork to mainstream | EU-Startups

One thought on “Cambridge-based Uncommon raises €28 million to scale cultivated pork to mainstream”

Comments are closed.